In this Issue:
Very low PSA levels and cancer-specific death
Predictors of quality of prostate cancer surveillance
Dose-intensified salvage radiation therapy
Enzalutamide vs bicalutamide for metastatic prostate cancer
Docetaxel or bisphosphonates for hormone-sensitive prostate cancer
PLND in locally advanced prostate cancer
HIFU hemiablation for clinically localised prostate cancer
Outcomes of focal irreversible electroporation for prostate cancer
Please login below to download this issue (PDF)